news SARS-CoV-2 triggers antibodies from previous coronavirus infections 22 January 2021 | By Victoria Rees (Drug Target Review) A new study has shown that previous coronavirus infection may contribute to the immune response of patients infected with SARS-CoV-2.
article What is new in the world of imaging? 21 January 2021 | By Hannah Balfour (Drug Target Review) In this article, Drug Target Review’s Hannah Balfour discusses three of the latest developments in imaging for disease research and drug development.
news Scientists develop potential ‘smart’ stem cells made from human fat 21 January 2021 | By Victoria Rees (Drug Target Review) Using a new compound mixture, researchers have created adaptive and regenerative stem cells from human fat cells.
news Novel IRF4 inhibitor shows promise as myeloma treatment in mice 21 January 2021 | By Victoria Rees (Drug Target Review) An antisense oligonucleotide has been developed by researchers to inhibit IRF4 as a potential strategy to treat multiple myeloma.
article A novel CAR T-cell therapy to treat lymphomas 20 January 2021 | By Victoria Rees (Drug Target Review) A new form of CAR T-cell therapy has shown promise in mice models to treat blood cancers; this article delves into the development behind the therapy.
news CBD shown to kill Gram-negative bacteria in pre-clinical studies 20 January 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that CBD can kill Gram-negative bacteria, which could lead to the first new class of antibiotics for resistant bacteria in 60 years.
news Researchers discover mechanism behind severe cases of G6PD deficiency 20 January 2021 | By Victoria Rees (Drug Target Review) Researchers have revealed how the most severe cases of G6PD deficiency occur, which could help scientists design new drugs for the disease.
news New method for rapid development of vaccines for pre-clinical tests 19 January 2021 | By Victoria Rees (Drug Target Review) Using synthetic chemistry, researchers have fused hydrophobic adjuvants with water-soluble proteins to create a new type of vaccine.
news Knee injection shows promise as osteoarthritis treatment in mice 18 January 2021 | By Victoria Rees (Drug Target Review) Scientists have found that a new knee injection using nanomedicine could prevent the effects of osteoarthritis.
news Researchers link cellular transport pathway to glioblastoma 18 January 2021 | By Victoria Rees (Drug Target Review) A study has said that restoring a particular protein's activity could be a new therapeutic strategy to treat glioblastoma.
news Compound from Inula viscosa plant could treat primary amoebic meningoencephalitis 14 January 2021 | By Victoria Rees (Drug Target Review) Researchers have isolated a compound from I. viscosa that kills the "brain-eating" amoebae from primary amoebic meningoencephalitis (PAM).
news New inhaled therapy could treat deadly impacts of asthma 14 January 2021 | By Victoria Rees (Drug Target Review) Scientists have developed an inhaled treatment for asthma that prevents excess mucus from building up in mice.
article CRISPR: three new developments in the world of gene editing 14 January 2021 | By Victoria Rees (Drug Target Review) In this article, we outline three recent studies that have advanced the potential uses of CRISPR in the biomedical field.
news Nanoparticle vaccine could protect against multiple coronaviruses 13 January 2021 | By Victoria Rees (Drug Target Review) A new protein-based nanoparticle vaccine protected mice against a variety of coronaviruses, researchers have shown.
news Hydrogen sulphide could help to treat Alzheimer’s disease 13 January 2021 | By Victoria Rees (Drug Target Review) Tests in Alzheimer's disease mouse models have shown that hydrogen sulphide can improve cognitive and motor function by 50 percent.
